Expanding Medicaid to the relatively healthy might make sense if it improved general health. But there is little evidence it does. In Oregon, for example, a first-of-its-kind controlled trial tracked individuals who applied for Medicaid through a lottery. After two years, there was no discernible difference in the physical health of the winners and losers. More
In the near future, the elderly and the disabled will face a double whammy: higher premiums for Part D drug insurance and higher prices at the pharmacy. This is on top of negotiated prices (and the consequent drop in new drug production) which will kick in later in the decade.
John Goodman and Linda Gorman explain why this will happen in The Hill.
Congressional Democrats are proposing to spend an enormous amount of taxpayer dollars on what the New York Times calls a “cradle to the grave” addition to U.S. social welfare. When budgeting shenanigans are ignored, the Committee for a Responsible Federal Budget estimates that the full cost is not the $3.5 trillion that has been widely advertised, but at least $5.0 trillion and possibly as much as $5.5 trillion.
A frequent criticism of US hospitals is the charge of excessive adverse medical events, sometimes leading to avoidable deaths. How do our hospitals compare to hospitals in national health care systems? Quite well. The percent of patients who experience an adverse event is twice as high in Canada, three times as high in Britain and four times as high in New Zealand.
This article was coauthored by Linda Gorman, director of health care at the Independence Institute in Denver, Colorado.
The Trump administration wants to use an average of the drug prices paid by other countries to limit what Medicare Part B pays for some drugs. This is a bad idea.
The percent of the population with private health insurance actually declined during the eight years of the Obama presidency, according to a study by health economist Linda Gorman.
The federal government spent $341 billion from 2014 through 2016 on subsidizing individual coverage so that people would buy it (Not counting the money spent on state and federal exchanges).
The Medicare Payment Advisory Commission has voted to recommend scrapping the Merit-Based Incentive Payment System because it “cannot succeed.”
You know you are in the silly season when the charges against sensible tax reform become more and more outrageous. The silliest and most outrageous is based on this causal reasoning: The Republican tax measure repeals the Obamacare mandate, requiring people to purchase health insurance; without the mandate, fewer people will insure; and without insurance, more people will die.